Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
oleh: Sarah McLaughlin, Brian McNeill, James Podrebarac, Katsuhiro Hosoyama, Veronika Sedlakova, Gregory Cron, David Smyth, Richard Seymour, Keshav Goel, Wenbin Liang, Katey J. Rayner, Marc Ruel, Erik J. Suuronen, Emilio I. Alarcon
| Format: | Article |
|---|---|
| Diterbitkan: | Nature Portfolio 2019-10-01 |
Deskripsi
Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.